Correlation Between Apellis Pharmaceuticals and HUTCHMED DRC
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and HUTCHMED DRC, you can compare the effects of market volatilities on Apellis Pharmaceuticals and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and HUTCHMED DRC.
Diversification Opportunities for Apellis Pharmaceuticals and HUTCHMED DRC
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Apellis and HUTCHMED is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and HUTCHMED DRC go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and HUTCHMED DRC
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.1 times more return on investment than HUTCHMED DRC. However, Apellis Pharmaceuticals is 1.1 times more volatile than HUTCHMED DRC. It trades about 0.07 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.05 per unit of risk. If you would invest 2,947 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 244.00 from holding Apellis Pharmaceuticals or generate 8.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. HUTCHMED DRC
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| HUTCHMED DRC |
Apellis Pharmaceuticals and HUTCHMED DRC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and HUTCHMED DRC
The main advantage of trading using opposite Apellis Pharmaceuticals and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| HUTCHMED DRC vs. Capricor Therapeutics | HUTCHMED DRC vs. Soleno Therapeutics | HUTCHMED DRC vs. Bio Path Holdings | HUTCHMED DRC vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |